Sign Out
Active ingredient: Bevacizumab (humanised anti-VEGF monoclonal antibody).
MVASI is a biosimilar medicine to the reference product AVASTIN (bevacizumab). The evidence for comparability supports the use of MVASI for the listed indications.
Excipients/Inactive Ingredients: Trehalose dihydrate, Sodium phosphate, Polysorbate, Water for injections.
